- Chemtrade Logistics reported a net income of C$60.1 million for the third quarter.
- This net income marks a 15% decrease compared to the same period last year.
- Despite the decrease, the net income surpassed analysts’ estimates of C$43.1 million.
- The company’s revenue for the third quarter was C$474.2 million.
- Revenue saw a slight decline of 1.9% compared to the previous year.
- However, this revenue figure exceeded the estimated C$463.8 million.
- Adjusted EBITDA stood at C$137.2 million, down by 3.5% year-over-year.
- The adjusted EBITDA result also exceeded market expectations of C$121.1 million.
- Market sentiment remains positive with 6 buy ratings, 1 hold, and no sell ratings for Chemtrade.
A look at Chemtrade Logistics Income Fun Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Chemtrade Logistics Income Fund shows strong momentum and solid scores in dividend and growth potential. These factors indicate a positive long-term outlook for the company, suggesting it may offer attractive returns to investors over time. While the resilience score is relatively lower, the overall outlook remains promising due to the robust performance in other key areas.
Chemtrade Logistics Income Fund, a trust established in Ontario, holds securities of Chemtrade Logistics Inc. The company specializes in the bulk chemical industry, focusing on removal, storage, marketing, and distribution of chemicals obtained under long-term agreements. With a mix of strong dividend, growth, and momentum scores, coupled with its specific industry focus, Chemtrade Logistics Income Fund presents a compelling investment opportunity for those seeking potential long-term gains.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
